The Latest Breaking News from FDA

The Biden administration on Monday asked a federal appeals court to allow women to continue to be able to access to the most commonly used abortion drug in the U.S. while a lawsuit over it plays out

ATLANTA — The Food and Drug Administration has taken up the regulation of tobacco products as a key issue to focus on in 2023, particularly prohibiting the sale of menthol cigarettes and flavored cigars and cigarillos.

Backlash could box Republicans into defending unpopular policies in 2024.

A medical ethics expert says a Texas abortion pill ruling is unprecedented because a federal judge "standing in" for regulators could have far-reaching implications beyond mifepristone.

On Friday, federal Judge Matthew Kacsmaryk handed down a decision further restricting abortion access nationwide by suspending the Food and Drug Administration’s approval of mifepristone, the most common and safe pill used for medication abortion. Another ruling, from a federal judge in Washington state, ordered the F.D.A. to make no…

The drug mifepristone is safe. In fact, what’s unsafe is its absence, as the lack of the crucial abortion-inducing drug will push women to have abortions in more dangerous ways, which is why it’s been FDA-approved for more than 20 years.

Massachusetts, California and Washington pledge to provide medication after a federal judge invalidated 23-year FDA approval

WASHINGTON — The Biden administration asked a federal appeals court to suspend a ruling by a conservative U.S. judge in Texas that would block access nationwide to a key drug used in medication abortions — even as it sought clarity on a conflicting order in Washington state.

Advocates, providers, medical groups and drugmakers wrestle with uncertainty, confusion and frustration